LYTIR

Insider · SEC Form 4 · Chief Financial Officer

Maged Shenouda

Filed with the SEC as Shenouda Maged; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $844K of RLMD. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. RLMDBought: RELMADA THERAPEUTICS, INC. Sep 10, 2026 79,800 shares filed Sep 11, 2026 1,000,000 shares held directly after, as filed filing $339K
  2. RLMDBought: RELMADA THERAPEUTICS, INC. Sep 9, 2026 120,200 shares filed Sep 11, 2026 920,200 shares held directly after, as filed filing $505K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.